Mechanism of lesion production in pemphigus and pemphigoid - PubMed (original) (raw)
Review
Mechanism of lesion production in pemphigus and pemphigoid
W M Sams Jr et al. J Am Acad Dermatol. 1982 Apr.
Abstract
Current evidence strongly supports the theory that the lesions of pemphigus are due to binding of pemphigus antibody to an antigen in or near the epidermal cell membrane, which causes a release of at least one enzyme which results in dissolution of the intercellular attachments and acantholysis. Similarly, strong evidence supports the hypothesis that pemphigoid blisters are due to binding of antibody at the basement membrane, followed by activation of complement and release of anaphylatoxins which activate tissue mast cells to release eosinophil chemotactic factor. These eosinophils then release tissue-destructive enzymes and reactive oxygen intermediates directly onto the basement membrane zone, with loss of dermoepidermal adherence and formation of blisters.
Similar articles
- Immunopathologic mechanisms in pemphigus and bullous pemphigoid.
Jordon RE, Kawana S, Fritz KA. Jordon RE, et al. J Invest Dermatol. 1985 Jul;85(1 Suppl):72s-78s. doi: 10.1111/1523-1747.ep12275497. J Invest Dermatol. 1985. PMID: 3891883 Review. - Mast cell-dependent effector pathways and cutaneous bullous disorders.
Wintroub BU, Mihm MC. Wintroub BU, et al. Springer Semin Immunopathol. 1981 Jun;4(1):65-72. doi: 10.1007/BF01891886. Springer Semin Immunopathol. 1981. PMID: 7022723 Review. No abstract available. - Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin.
Gammon WR, Lewis DM, Carlo JR, Sams WM Jr, Wheeler CE Jr. Gammon WR, et al. J Invest Dermatol. 1980 Oct;75(4):334-9. doi: 10.1111/1523-1747.ep12531082. J Invest Dermatol. 1980. PMID: 7000926 - An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement.
Gammon WR, Merritt CC, Lewis DM, Sams WM Jr, Carlo JR, Wheeler CE Jr. Gammon WR, et al. J Invest Dermatol. 1982 Apr;78(4):285-90. doi: 10.1111/1523-1747.ep12507222. J Invest Dermatol. 1982. PMID: 7040558 - Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
Anhalt GJ, Patel H, Diaz LA. Anhalt GJ, et al. Arch Dermatol. 1983 Sep;119(9):711-4. Arch Dermatol. 1983. PMID: 6351756 Review. No abstract available.
Cited by
- Targeting interleukin 4 and interleukin 13: a novel therapeutic approach in bullous pemphigoid.
Chen F, Wang Y, Chen X, Yang N, Li L. Chen F, et al. Ann Med. 2023 Dec;55(1):1156-1170. doi: 10.1080/07853890.2023.2188487. Ann Med. 2023. PMID: 36999962 Free PMC article. Review. - Autoantibody Signaling in Pemphigus Vulgaris: Development of an Integrated Model.
Sajda T, Sinha AA. Sajda T, et al. Front Immunol. 2018 Apr 19;9:692. doi: 10.3389/fimmu.2018.00692. eCollection 2018. Front Immunol. 2018. PMID: 29755451 Free PMC article. Review. - Pemphigus autoimmunity: hypotheses and realities.
Grando SA. Grando SA. Autoimmunity. 2012 Feb;45(1):7-35. doi: 10.3109/08916934.2011.606444. Epub 2011 Sep 23. Autoimmunity. 2012. PMID: 21939410 Free PMC article. Review. - Pemphigus and pemphigoid in domestic animals: an overview.
Ackerman LJ. Ackerman LJ. Can Vet J. 1985 Jun;26(6):185-9. Can Vet J. 1985. PMID: 17422541 Free PMC article. - Eosinophil infiltration in three patients with generalized atrophic benign epidermolysis bullosa from a Japanese family: molecular genetic and immunohistochemical studies.
Nomura M, Hamasaki YI, Katayama I, Abe K, Niikawa N, Yoshiura KI. Nomura M, et al. J Hum Genet. 2005;50(9):483-489. doi: 10.1007/s10038-005-0282-4. Epub 2005 Sep 20. J Hum Genet. 2005. PMID: 16172808
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical